SCHEMBL30962719

SCHEMBL30962719

COc1nc(Nc2ccc(C3CCN(C)CC3)c(C#N)c2)ncc1C(=O)Nc1c(Cl)ccc(O[Si](C)(C)C(C)(C)C)c1C

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 7/20 0.40
▸ PKMYT1 Q99640 2/20 0.39
▸ LCK P06239 2/20 0.38
▸ KDR P35968 1/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ TEK Q02763 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ TNK2 Q07912 1/20 0.38
▸ TBK1 Q9UHD2 2/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ BRD4 O60885 3/20 0.37
▸ WEE1 P30291 1/20 0.37
▸ SIK1 P57059 1/20 0.37
▸ SIK2 Q9H0K1 1/20 0.37
▸ SIK3 Q9Y2K2 1/20 0.37
▸ SRC P12931 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962908 0.92 WEE1 (0.43) LCKKDRJAK3TEKMAPK14
SCHEMBL30962937 0.88 PTK2 (0.42) PTK2PKMYT1LCKKDRJAK3
SCHEMBL30962922 0.88 WEE1 (0.44) LCKKDRJAK3TEKMAPK14
SCHEMBL30962817 0.86 LCK (0.43) LCKKDRJAK3TEKMAPK14
SCHEMBL30962750 0.86 TTK (0.40) LCKKDRJAK3TEKMAPK14
SCHEMBL30962685 0.84 SRC (0.38) PTK2LCKKDRJAK3TEK
SCHEMBL30962656 0.82 WEE1 (0.49) PTK2LCKKDRJAK3TEK
SCHEMBL30962858 0.80 EHMT2 (0.37) PTK2PKMYT1JAK3TBK1JAK2
SCHEMBL30962941 0.80 LCK (0.44) PTK2LCKKDRJAK3TEK
SCHEMBL30962812 0.80 WEE1 (0.47) PTK2LCKKDRJAK3TEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback